Julio-Septiembre 2010 43
ISSN 1317-987X
 
Buscar




Artículos
 



Anatomía Patológica
Inmunohistoquímica diagnóstica en metástasis ováricas

Referencias

1-Lash RH,Hart WR. Intestinal adenocarcinomas metastatic to the ovaries. A clicopathologic evaluation of 22 cases. Am J Surg Patol 1987; 11: 114-121.

2-McCluggage WG. Recent advances in immunohistochemistrry in the diagnosis of ovarian neoplasms. J Clin Pathol 2000; 53: 558-560.

3-Joshi VV. Primary Krukemberg tumor of ovary. Review of the literature and case report. Cancer 1968; 22: 1199-1207.

4-Mrad K, Morice P, Febre A, Pautier P, y col. Krukemberg tumor: a clinicopathologic study of 15 cases. Ann Pathol 2000; 20: 202-206.

5-Vang R, Bague S, Tavassoli FA, Prat J. Signet-ring stromal tumor of the ovary: clinicopathologic analysis and comparison with Krukemberg tumor. Int J Gynecol Pathol 2004; 23: 45-51.

6-Suarez A, Palacios J, Burgos E, Gamallo C. Signet-ring stromal tumor of the ovary: a histochemical, immunohistochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1993; 422: 333-325.

7-Bullon A, Arseneau J, Prat J, Young RH, Scully RE. Tubular Krukemberg tumor. A problem in histopathologic diagnosis. Am J SurgPathol 1981; 5: 225-232.

8-Prat J, Morice P. Secondary Tumors of the ovary. Tumours of the breast and female organs. In Pathology & Genetics. WHO Classification of Tumours. Tavassoli FE & Devilee P. Edits. IARC Press, Lyon, 2003; 193-196.

9- García Tamayo J, Hernádez C. La inmunohistoquímica en el cáncer metastásico. En Vital-Academia Biomédica digital, http://caibco.ucv.ve/Vitae/Vitae Catorce. Enero-marzo, 2002

10- Deavers MT, Malpica A, Liu J, Broaddus R, Silva EG. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 2003; 16 :584-590.

11-Movahedi-Lankarani S, Kurman R J. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms. An immunohistochemical study of 215 cases. Am J Surg Pathol 2002; 26 :1477-1483.

12- Berezoswski K, Stastny JF, Kornstein MJ. Cytokeratins 7 and and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 1995; 9: 426-429.

13- Chu PG, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000; 13: 962-972.

14-Park SO, Kim HS, Hong eK, Kim AWH. Expression of cytokeratin 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas of the ovary. Human Pathol 2002; 33: 1078-1085.

15-Birnkrant A, Sampson J, Sugarbaker PH. Ovarian metastases from colorectal cancer. Dis Colon Rectum 1986; 29: 767-771

16-Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incident in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003; 27: 985-993.

17-Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinoma in the ovary. Gross and histologic findings in 50 cases. Am J Surg Pathol 2003; 27: 281-292.

18-Vang R, Ronnett BM. Distinction of primary ovarian mucinous tumors and mucinous tumors metastatic to the ovary. A practical approach with guidelines for prediction of primary site for metastases of uncertain origin. Pathology Case Reviews 2006; 11: 18-30.

19- Loy TS, Calaluce RD, Kenney GL. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 1996; 1: 1040-1044.

20-Berezowski K, Stantny JF, Kornstein MJ. Cytokeratin 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 1996; 9: 426-429.

21-Ji H, Isacson C, Seidman JD, Kurman RJ, Ronnett BM. Cytokerantin 7 and 20, Dpc4 and MUC5AC in the distinction of metastatic carcinoma mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol 2002; 21: 391-400.

22- Palacios J, Gamallo C. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 1998; 58: 1344-1347.

23-Chou YY, Jen YM, Kao HL, Chen T, Mao TL, Lin MC. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with β-catenin. Histopathology 2003; 43: 151-153.

24-Ronnet BM, Kurman RJ, Shmookler BM, Sugarbaker PH, Young RH. The morphologic spectrum of ovarian metastases of appendiceal adenocarcnomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 1997; 21:1144-1155.

25-Ronnet BM, Kurman RJ, Zahn CM y col. Pseudomyxoma peritonei in woman: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis and relationship to ovarian tumors of low malignant potential. Human Pathol 1995; 56: 509-524.

26-Seidman JD, Elsayed AM, Sobin LH, Tavassoli FA. Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases. Am J Surg Pathol 1993; 17:22-23.

27-Guerrieri C, Frandlund B, Boeryd B. Expression of cytokeratin 7 in simultaneous mucin tumors of the ovary and appendix. Mod Pathol 1995; 8: 573-576.

28-Ronnet BM, Seidman JD. Mucinous tumors arising in ovarian mature cystic teratomas. Relatioship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol 2003; 27: 650-657.

29-Lee KR, Scully R. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors ( of intestinal type ) and carcinomas, including an evaluation of 11 cases with psudomyxoma peritonei. Am J Surg Pathol 2000; 24: 1447-1464.

30-Merino MJ, Edmonds P, LiVolsi V. Appendiceal carcinoma metastatic to the ovaries and mimicking primary ovarian tumors. Int J Gynecol Pathol 1985; 4:110-120.

31-Young RH, Hart WR. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary: a report of seven cases. Am J Surg Pathol 1989; 13: 748-756.

32-Young RH, Scully RE. Ovarian metastases from carcinoma of the gallbladder and extrahepatic bile ducts simulating primary tumors of the ovary: a report of six cases. Inst J Gynecol Pathol 1990; 9: 60-72.

33-Young RH, Hart WR. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary: a report of seven cases. Am J Surg Pathol 1989; 13: 748-756.

34-Duval JV, Savas L, Banner BF. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladeer. Arch Path Lab Med 2000; 124: 1198-1200.

35-Low JJ, Chew SH, Chew SP, y col. A rare case of metastatic ovarian carcinoma originating from primary intrahepatic cholangiocarcinoma: case report. Eur J Gynecol Oncol 2003; 24: 85-88.

36- Goldstein NS, Bassi D, Uzieblo A. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol 2001; 116: 246-252.

37-Hashi A, Yuminamochi T, Murata SI, y col. Wilms Tumor Gene immunoreactivity in primary serous carcinomas of the Fallopian tube, ovary, endometrium and peritoneum. Int J Gynecol Pathol 2003; 22: 374-377.

38-Kurman RJ, Seidman JD,Shih I-M. Expert opinion. Serous borderline tumours of the ovary. Histopathol 2005; 47:310-318.

39-Worsley SD, Ponder BA, Davies BR. Overexpression of ciclin D1 in epithelial ovarian cancers. Gynecol Oncol 2005; 29:218-224.

40-Singer G, Stohr R, Cope L y col. Patters of p53 mutations separate ovarian serous borderline tumours and low-and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis:a mutational analysis with immunohistochemical correlation. Am J Surg Pathol 2005; 29: 218-224.

41-Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Inst J Gynecol Pathol 2005; 25: 83-89.

42-Ronnett BM, Kajdacsy-Balla A, Gilks CB, y col. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol 2004; 35: 949-960.

43-Longacre TA, McKenney JK, Tazealaar HD, y col. Ovarian serous tumors of low malignant potential (borderline tumors ):outcome based study of 276 patients with long-term ( +5 year ) follow-up. Am J Surg Pathol 2005; 29: 707-723.

44-Heinrich JK, Bottcher-Luiz F, Andrade LL, y col. Her-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization. Int J Gynecol Cancer 2004; 14: 1978-1085.

45-Al-Hussaini M, Stockman A, Foster H, y col. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and distinghishing between serous and endometrioid ovarian carcinoma. Histopathology 2004; 44:109-115.

46-Lee ES, Leong A S-Y, Kim Y-S, Lee J-H, y col. Calretinin, CD34 and a-smooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary. Modern Pathol 2006; 19: 364-372.

47-Young RH, Scully RE. Urothelial and ovarian carcinomas of identical cell types: problems in interpretation. A report of three cases and review of the literature. Int J Gynecol Pathol 1988; 7: 197-211.

48-Riedel I, Czernobilsky B, Lifschitz-Mercer B, y col. Brenner tumors but no trasitional cell carcinoma of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchow Arch 2001; 438: 181-191.

49-Logani S, Oliva E, Amin MB, y col. Immunoprofile of ovarian tumors with putative transitional cell ( urothelial) differentiation using novel urothelial markers. Histogenetic and diagnostic implications. Am J Surg Pathol 2003; 27: 1434-1441.

50-Ordoñez NG, Mackay B. Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder. Ultrastruct Pathol 2000, 24: 157-167.

51-Zaino RJ, Unger ER, Whitney C. Syncronous carcinomas of the uterine corpus and ovary. Gynecol Oncol 1984; 19: 329-335.

52-Prat J, Matias-Guiu X, Barreto J. Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immnuohistochemistry and DNA flow cytometric study of 18 cases. Cancer 1991; 65: 2455-2459.

53-McGluggage WG, Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathol 2005; 47: 231-247.

54-Pins MR, Young RH, Crum CP, y col. Cervical squamous carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papillomavirus analysis. Int J Gynecol Pathol 1997; 16: 272-278.

55-Struewing JP, Hartage P, Wacholder S, y col. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-1408.

56-Gagnon Y, Tetu B. Ovarian metastases of breast carcinoma. A clinico-pathologic study of 59 cases. Cancer 1989; 64: 892-898.

57-García Tamayo J, Blasco Olaetxea E, Morales A, Molina J, Guzmán Bistoni C, Szurba E, Méndez V. Importancia de la expresión de E-cadherina en el diagnóstico inmunohistoquímico del cáncer de mama. Aceptado para ser publicado en Invest Clin, Ven, 2006.

58-Young RH, Hart WR. Renal cell carcinoma metastatic to the ovary: a report of three cases emphasizing possible confusion with ovarian clear cell carcinoma. Int J Gynecol Pathol 1992; 11: 96-102.

59-Nolan LP, Heatley MK. The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary. Int J Gynecol Pathol 1988; 7: 197-211.

60-Cameron RI, Ashe P, O´Rourke DM, Foster H, McCluggage WG. A panel of immunohistochemical stains assits in the distinction between ovarian and renal clear cell carcinoma. Int J Gynecol Pathol 2003; 3: 272-276.

61-Langer C, Ratschek M, Rehak P, Schips L, Zigeuner R. Steroid hormonones receptor expression in renal cell carcinoma. Immunohistochemical analysis of 182 tumours. J Urol 2004; 171: 611-614.

62-Morales A, Hernández C, García Tamayo J, Blasco Olaetxea E. Importancia del Factor de Transcripción Nuclear Tiroideo (TTF-1) en el diagnóstico de adenocarcinoma metastático. Estudio inmunohistoquímico de 40 casos. En Vitae-Academia Biomédica digital. http://caibco.ucv.ve/caibco/CAIBCO/Vitae/VitaeDiecinueve/ Abril-Junio, 2004.

63-Young RH, Gersell DJ, Clemente PB, Scully RE. Hepatocellular carcinoma metastatic to the ovary: a report of three cases discovered during life with discussion of the differential diagnosis of hepatoid tumors of the ovary. Human Pathol 1992;23: 574-580.

64-Pitman MB, Triratanachat S, Young RH, Oliva E. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Inst J Gynecol Pathol 2004; 23: 58-64.

65-Young RH, Scully RE. Malignant melanoma metastasic to the ovary: a clinicopathologic analysis of 20 cases. Am J Surg Pathol 1991; 15: 849-860.

66-Vimla N, Kumar L, Thulkar S, Bal S, Dawar R. Primary malignant melanoma in ovarian cystic teratoma. Gynecol Oncol 2001; 82: 380-383.

67- García Tamayo J, Hernández C. Diagnóstico inmunohistoquímico de los tumores malignos de células redondas. En Vitae-Academia Biomédica digital. http://caibco.ucv.ve/caibco/CAIBCO/Vitae/VitaeDiez/Articulos/AnatomiaPatologica/

Enero-marzo 2002

Inmunohistoquímica diagnóstica en metástasis ováricas
Introducción
Material y métodos
Resultados
Discusión
Referencias

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit